Mitoxantrone: a hypomethylating agent?
Yang
Allen S
AS
Department of Leukemia, University of Texas at M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Issa
Jean-Pierre J
JP
D000951:Antigens, Neoplasm / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018736:DNA Adducts; D019175:DNA Methylation; D015972:Gene Expression Regulation, Neoplastic; D020868:Gene Silencing; D006801:Humans; D008942:Mitoxantrone / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D018736:DNA Adducts; D008942:Mitoxantrone